about
sameAs
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasiaTreatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxiaMesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension.Inhaled iloprost for severe pulmonary hypertension.Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension - Insights From the IBUKI and AIR Studies.The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension.Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteriesDiagnosis and differential assessment of pulmonary arterial hypertension.Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction.Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.Cellular pathophysiology and therapy of pulmonary hypertension.Double-stranded RNA attenuates the barrier function of human pulmonary artery endothelial cells.Aerosolized vasodilators in pulmonary hypertension.Diagnosis and assessment of pulmonary arterial hypertension.Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilizationEvaluation of elevated mean pulmonary arterial pressure based on magnetic resonance 4D velocity mapping: comparison of visualization techniques.Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertensionBorderline pulmonary pressures in scleroderma - a 'pre-pulmonary arterial hypertension' condition?Sleep Related Breathing Disorders and Inflammation - The Missing Link? A Cohort Study Evaluating the Interaction of Inflammation and Sleep Related Breathing Disorders and Effects of Treatment.Prostacyclin and its analogues in the treatment of pulmonary hypertension.Prostanoid therapy for pulmonary arterial hypertension.TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers.Counter-clockwise vortical blood flow in the main pulmonary artery in a patient with patent ductus arteriosus with pulmonary arterial hypertension: a cardiac magnetic resonance imaging case reportUse of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.Docosahexaenoic acid-induced unfolded protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca²⁺-dependent induction of oxidative stressBaseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension.Aspergillus oryzae peritonitis in CAPD: case report and review of the literature.Prostacyclin therapies for the treatment of pulmonary arterial hypertension.The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension.Native myocardial T1 mapping in pulmonary hypertension: correlations with cardiac function and hemodynamics.Quantification of tortuosity and fractal dimension of the lung vessels in pulmonary hypertension patientsPortopulmonary hypertension: short review.Biomarkers in pulmonary hypertension: what do we know?Prostacyclins.Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings.
P50
Q24302138-DDCFB1E2-FB79-4150-A9C8-BDCAFB4CA86DQ26830290-0C9B2CEB-991D-47EE-981E-1A5ABF08D0B5Q28239012-70353563-CE5F-44F5-BE1D-2799184F940DQ28392429-B62D82C6-9B50-4849-B5CA-34C6DB6D264BQ30987035-CA9A9D25-2A62-45F0-B7D9-3D9C5DFE421FQ33147955-1B161E59-CB4A-4B74-89E1-75BA12BF6D46Q33166962-2B492A3F-9F6F-43B2-B1A0-A1F79FB53E77Q33692813-756050F9-DF11-4C0D-B13F-5788D57ADCC1Q33788554-85C8CC86-4906-4010-A8AE-7A00826B2887Q33890202-99D894A4-8A21-41C7-A052-757636844691Q34326663-64F816F2-DA94-4C62-BD9F-4B7F3D8F2BFBQ34391833-17461B6A-A1F6-4BD5-93CF-018114DD4766Q34402406-16A4F738-7F3A-4348-9B72-29D0603EB37CQ34468643-24313AF0-E82E-4E29-8954-36ACE99B5175Q34765604-2520551D-E99A-4754-BD4C-5584EA86BC53Q34787966-F9D07DBE-025E-46BF-B90D-96ADDACA7B2AQ34989034-19CD16AA-DBEF-4DA9-849F-DE20B74C7285Q34989038-1D843AD7-01FB-40AD-B28E-51C23F02CB72Q35059923-6441B2F5-E5BC-4986-BD42-A49CC4D5C099Q35070065-35DF21D2-8780-4EAB-96CA-8D8933FF5742Q35185797-C3D2DE2C-DDCF-46E5-9D25-7D53880DB932Q35444290-7E1E5DF7-78F2-4831-8AD6-2D3A44887DA7Q35620391-5D0DB1DF-F3A2-4BE1-9672-DF0D90E7C596Q35769328-B9C5CF8D-066F-4FD1-8ACE-9469B67F64B6Q35784321-B96A0F66-9DAB-421B-A05D-5C141F013B4DQ35803359-B1EACC8B-F906-4834-9B99-A1F014832462Q36050237-ED5F58A2-B464-4C92-B168-591A8D2F804EQ36097732-7960AB6A-7E57-4976-9D30-A4D8DCD9F30BQ36234697-B06EE7D5-79E5-4424-9F16-3D85F3054E8AQ36351965-91DDB30A-8D47-4D2B-A313-5722B1BDB6D6Q36411409-521AD2BF-49E9-4153-9F39-511FCEC6A735Q36808191-D99E3553-5F55-4E3D-A08A-2D8F7842AE4DQ37124222-0E04EEE4-C9D2-452D-86D3-4279B22C4BECQ37328981-F513E353-0541-44EA-9334-EDD4EAE37A8EQ37452724-54A9C230-1CBD-4507-820C-5EA88C98953CQ37538797-50B7AF92-BC22-4825-8C4F-D6424A23C38EQ37631393-7503F02A-2F01-4426-9DD4-CF7EEA7F7F92Q38123638-273CBD9E-9E6B-42AE-94DC-3B0E8B094D39Q38149029-9841524E-0573-4BFF-95FE-CF7492DE7F0BQ38215536-D27E3FB5-BB77-46B3-9DA5-3D1C79972416
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Horst Olschewski
@ast
Horst Olschewski
@en
Horst Olschewski
@es
Horst Olschewski
@nl
Horst Olschewski
@sl
type
label
Horst Olschewski
@ast
Horst Olschewski
@en
Horst Olschewski
@es
Horst Olschewski
@nl
Horst Olschewski
@sl
prefLabel
Horst Olschewski
@ast
Horst Olschewski
@en
Horst Olschewski
@es
Horst Olschewski
@nl
Horst Olschewski
@sl
P214
P244
P106
P21
P213
0000 0000 3933 0382
P214
P244
n2002134464
P2798
P31
P496
0000-0002-2834-7466
P734
P735
P7859
lccn-n2002134464